Stock Selection: Gemini 1.5 Pro's picks for 2026-09-09
Gemini 1.5 Pro picked CRWV, ROIV, INTC, LITE, META for a 1-day horizon. Portfolio return vs SPY: +1.51%. Picks that beat SPY: 80%.
| Experiment | Stock Selection |
|---|---|
| Model | Gemini 1.5 Pro |
| Prompt version | stock-selection-v6 |
| Asked | |
| Horizon | 1-day |
| Measured from | 2026-09-08 |
| Measured to | 2026-09-09 |
| Benchmark | SPY |
| Status | Settled |
| Portfolio return vs SPY | +1.51% |
| Picks that beat SPY | 80% |
| Benchmark return | -0.46% |
The picks
| Rank | Symbol | Return | Confidence | vs benchmark | Called right |
|---|---|---|---|---|---|
| 1 | CRWV | -4.90% | 85% | -4.43% | No |
| 2 | ROIV | +0.80% | 80% | +1.26% | Yes |
| 3 | INTC | +1.69% | 75% | +2.16% | Yes |
| 4 | LITE | +1.07% | 70% | +1.53% | Yes |
| 5 | META | +6.55% | 65% | +7.02% | Yes |
The model's market view
US equities are facing headwinds from surging oil prices approaching $100/bbl due to Middle East tensions, alongside elevated Treasury yields following a strong August jobs report. However, individual tech and healthcare stocks with strong idiosyncratic catalysts—such as earnings beats, product launches, or clinical trial successes—are positioned to significantly outperform the broader market's defensive posture.
Why each pick
CRWV
CoreWeave reported strong second-quarter earnings, driving the stock up over 11% in post-market trading on September 8. As a key cloud computing provider for AI workloads, the company is benefiting from secular tailwinds that insulate it from broader macroeconomic weakness. The primary risk is broad tech-sector multiple compression from rising Treasury yields, but the magnitude of the earnings beat should easily drive outperformance against the SPY over a 1-day horizon.
ROIV
Roivant Sciences announced positive Phase 2 trial results for its subsidiary Pulmovant's mosliciguat, sending the stock surging nearly 19% in after-hours trading. This clinical milestone derisks the pipeline and attracts heavy momentum buying. While biotech is inherently volatile and prone to 'sell-the-news' intraday fading, the massive overnight gap from the September 8 close guarantees substantial outperformance versus the benchmark for this session.
INTC
Intel received a major upgrade from Northland Securities to 'Outperform' with a $120 price target, sparking a 7.5% rally during regular hours and continued strength in post-market trading. The upgrade highlights improving sentiment around Intel's turnaround and foundry business. The risk is that a broader semiconductor selloff could dampen its momentum, but the fresh analyst catalyst and high relative volume provide a strong buffer to beat the S&P 500.
LITE
Lumentum jumped 8% on September 8 due to surging demand for its optical networking products from artificial intelligence data centers. This validates the company's critical position in the AI hardware supply chain. Although exposed to supply-chain constraints and general market risk-off sentiment, the acute demand for AI infrastructure offers a strong fundamental floor that should allow it to outpace the broader market.
META
Meta Platforms demonstrated extreme relative strength on September 8, reversing intraday losses to close up 1.25% against a declining market after unveiling its new 'Muse' personal AI agent. This product launch reignited investor enthusiasm for Meta's AI monetization capabilities. The main risk is a rotation out of mega-cap tech if the 10-year yield continues to spike, but Meta's idiosyncratic product momentum gives it a clear edge over the SPY.
Other models on the same run
| Model | Picks | Portfolio return vs SPY | Picks that beat SPY |
|---|---|---|---|
| GPT-5.6 Sol | MU, AMD, QCOM, CEG, BE | +0.97% | 60% |
| Muse Spark 1.1 | SNDK, CBRS, SOXL, CEG, IONQ | -0.67% | 40% |
| Grok 4.5 | INTC, MU, AMD, GLW, XLE | +2.43% | 100% |
| DeepSeek V3 | IONQ, CEG, CHYM, AVO, AAPL | +1.15% | 60% |
| Claude Opus 5 | XLE, COP, MU, LNG, INTC | +1.73% | 100% |
Written up on ForecastNest Insights: Stock Selection: Gemini 1.5 Pro's picks for 2026-09-09.
ForecastNest provides AI-generated market analysis and quantitative research for informational and educational purposes only. Nothing here constitutes financial, investment, legal, or tax advice.